Why is REGENXBIO, Inc. ?
- The company has been able to generate a Return on Equity (avg) of 3.20% signifying low profitability per unit of shareholders funds
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 40.40%, its profits have risen by 38.9%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is REGENXBIO, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD -87.88 MM
Higher at USD 110.37 MM
Higher at USD -64.79 MM
Fallen by -68.75% (YoY
Highest at 6.82 times
At USD 21.36 MM has Fallen at -45.48%
Highest at -24.15 %
Highest at USD 10.99 MM
Lowest at USD -59.37 MM
Lowest at -277.98 %
Lowest at USD -70.87 MM
Lowest at USD -70.87 MM
Lowest at USD -1.38
Here's what is working for REGENXBIO, Inc.
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for REGENXBIO, Inc.
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Interest Paid (USD MM)
Interest Paid (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debt-Equity Ratio






